Shopping Cart 0
Cart Subtotal
USD 0

Global Blue Biotechnology Market (By Product Type- Pharma, Biofuels, Food, Enzymes, Biopolymers, and Others. By Application- Vaccine Development, Genomics, Drug Finding, and Others. By End- User- Pharmaceutical Companies, Biotechnology Companies, Research Organization, Healthcare Centre, and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4795

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 6795

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7795

Details

The report covers the analysis and forecast of the blue biotechnology market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (USD Mn).
 
The study provides a detailed view of the blue biotechnology market, by segmenting it based on by product type, by application, by end- user and regional demand. Robust growth of drug discovery in the past several years propels the growth for the blue biotechnologys market. Growing usage of algae along with other bacteria for producing a new drug is another prime factor driving the market demand. Additionally, extensive use of blue biotechnologys in end-user industries such as pharmaceutical, research organization, healthcare, and others boosts the demand of this market.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by product type, by application and end- user in all regions. These include different business strategies adopted by the leading players and their recent developments.
 
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the blue biotechnology market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the blue biotechnology market.
 
The report provides the size of the blue biotechnology market in 2017 and the forecast for the next eight years up to 2025. The size of the global blue biotechnology market is provided in terms of revenue. Market revenue is defined in USD Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.
 
Market estimates for this study have been based on revenue being derived through regional pricing trends. The blue biotechnology market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the blue biotechnology market, split into regions. Based on product type, application, and end- user, the individual revenues from all the regions is summed up to achieve the global revenue for blue biotechnology. Companies were considered for the market share analysis, based on their innovation, end- user and revenue generation. In the absence of specific data related to the sales of blue biotechnology several privately held companies, calculated assumptions have been made in view of the company's penetration and regional presence.
 
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Aker Biomarine, Cellgen Biologicals Pvt Ltd., Donald Danforth Plant Science Center, Geomarine Biotechnologies, Glycomar, Marinova, Nurture Aqua Technology Pvt., New England Biolabs, Pices, Pml Application Ltd., Sea Run Holdings, Inc., Shell Marine Products, Sanosil Biotech, and Samudra Biopharma Private Limited.
The global blue biotechnology market has been segmented into:
Global Blue Biotechnology Market: By Product Type
Pharma
Biofuels
Food
Enzymes
Biopolymers
Others
Global Blue Biotechnology Market: By Application
Vaccine development
Drug finding
Genomics
Others
Global Blue Biotechnology Market: By End- User
Pharmaceutical companies
Biotechnology companies
Research organization
Healthcare centre
Others
Global Blue Biotechnology Market: By Geography
North America
o U.S.
o Canada
o Mexico
Europe
o U.K.
o France
o Germany
o Italy
o Rest of Europe
Asia Pacific
o India
o China
o Japan
o Rest of Asia Pacific
Middle East and Africa
o South Africa
o Rest of Middle East and Africa
Latin America
o Brazil
o Rest of Latin America
READ MORE

Table Of Content

Scope

1 RESEARCH METHODOLOGY, ASSUMPTIONS AND ACRONYMS

2 EXECUTIVE SUMMARY

2.1 GLOBAL BLUE BIOTECHNOLOGY MARKET

3 GLOBAL BLUE BIOTECHNOLOGY MARKET-MARKET OVERVIEW

3.1 INTRODUCTION

3.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

3.1.2 GLOBAL BLUE BIOTECHNOLOGY MARKET SNAPSHOT

4 GLOBAL BLUE BIOTECHNOLOGY MARKET OVERVIEW- BY PRODUCT TYPE

4.1 INTRODUCTION

4.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY PRODUCT TYPE

4.1.1.1 PHARMA

4.1.1.2 BIOFUELS

4.1.1.3 FOOD

4.1.1.4 ENZYMES

4.1.1.5 BIOPOLYMERS

4.1.1.6 OTHERS

5 GLOBAL BLUE BIOTECHNOLOGY MARKET ANALYSIS AND FORECAST, BY APPLICATION

5.1 INTRODUCTION

5.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY APPLICATION

5.1.1.1 VACCINE DEVELOPMENT

5.1.1.2 GENOMICS

5.1.1.3 DRUG FINDING

5.1.1.4 OTHERS

6 GLOBAL BLUE BIOTECHNOLOGY MARKET ANALYSIS AND FORECAST, BY END- USER

6.1 INTRODUCTION

6.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY END- USER

6.1.1.1 PHARMACEUTICAL COMPANIES

6.1.1.2 BIOTECHNOLOGY COMPANIES

6.1.1.3 RESEARCH ORGANIZATION

6.1.1.4 HEALTHCARE SECTOR

7 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET, BY REGION

7.1 INTRODUCTION

7.2 KEY TAKEWAYS

8 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

8.1 MARKET DYNAMICS

8.1.1 DRIVERS

8.1.2 RESTRAINTS

8.1.3 OPPORTUNITIES

8.2 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE

8.3 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION

8.4 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER

8.5 U.S.

8.6 CANADA

8.7 MEXICO

9 EUROPE BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

9.1 MARKET DYNAMICS

9.1.1 DRIVERS

9.1.2 RESTRAINTS

9.1.3 OPPORTUNITIES

9.2 EUROPE BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE

9.3 EUROPE BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION

9.4 EUROPE BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER

9.5 U.K.

9.6 FRANCE

9.7 GERMANY

9.8 ITALY

9.9 SPAIN

9.10 REST OF EUROPE

10 ASIA PACIFIC BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

10.1 MARKET DYNAMICS

10.1.1 DRIVERS

10.1.2 RESTRAINTS

10.1.3 OPPORTUNITIES

10.2 ASIA PACIFIC BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE

10.3 ASIA PACIFIC BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION

10.4 ASIA PACIFIC BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER

10.5 INDIA

10.6 CHINA

10.7 JAPAN

10.8 REST OF ASIA PACIFIC

11 MIDDLE EAST AND AFRICA (MEA) BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

11.1 MARKET DYNAMICS

11.1.1 DRIVERS

11.1.2 RESTRAINTS

11.1.3 OPPORTUNITIES

11.2 MEA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE

11.3 MEA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION

11.4 MEA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER

11.5 SOUTH AFRICA

11.6 REST OF MIDDLE EAST AND AFRICA

12 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

12.1 MARKET DYNAMICS

12.1.1 DRIVERS

12.1.2 RESTRAINTS

12.1.3 OPPORTUNITIES

12.2 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE

12.3 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION

12.4 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER

12.5 BRAZIL

12.6 REST OF LATIN AMERICA

13 COMPETATIVE LANDSCAPE

13.1 GLOBAL BLUE BIOTECHNOLOGY MARKET-COMPANY MARKET SHARE ANALYSIS

14 COMPANY PROFILES: (REVENUE, PRODUCTS/BRAND OFFERINGS, COMPANY HIGHLIGHTS)

14.1 AKER BIOMARINE

14.2 CELLGEN BIOLOGICALS PVT LTD.

14.3 DONALD DANFORTH PLANT SCIENCE CENTER

14.4 GEOMARINE BIOTECHNOLOGIES

14.5 GLYCOMAR

14.6 MARINOVA

14.7 NURTURE AQUA TECHNOLOGY PVT.

14.8 NEW ENGLAND BIOLABS

14.9 PICES

14.10 PML APPLICATION LTD.

14.11 SEA RUN HOLDINGS, INC

14.12 SHELL MARINE PRODUCTS

14.13 SANOSIL BIOTECH

14.14 SAMUDRA BIOPHARMA PRIVATE LIMITED

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

The report covers the analysis and forecast of the blue biotechnology market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (USD Mn).
 
The study provides a detailed view of the blue biotechnology market, by segmenting it based on by product type, by application, by end- user and regional demand. Robust growth of drug discovery in the past several years propels the growth for the blue biotechnologys market. Growing usage of algae along with other bacteria for producing a new drug is another prime factor driving the market demand. Additionally, extensive use of blue biotechnologys in end-user industries such as pharmaceutical, research organization, healthcare, and others boosts the demand of this market.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by product type, by application and end- user in all regions. These include different business strategies adopted by the leading players and their recent developments.
 
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the blue biotechnology market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the blue biotechnology market.
 
The report provides the size of the blue biotechnology market in 2017 and the forecast for the next eight years up to 2025. The size of the global blue biotechnology market is provided in terms of revenue. Market revenue is defined in USD Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.
 
Market estimates for this study have been based on revenue being derived through regional pricing trends. The blue biotechnology market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the blue biotechnology market, split into regions. Based on product type, application, and end- user, the individual revenues from all the regions is summed up to achieve the global revenue for blue biotechnology. Companies were considered for the market share analysis, based on their innovation, end- user and revenue generation. In the absence of specific data related to the sales of blue biotechnology several privately held companies, calculated assumptions have been made in view of the company's penetration and regional presence.
 
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Aker Biomarine, Cellgen Biologicals Pvt Ltd., Donald Danforth Plant Science Center, Geomarine Biotechnologies, Glycomar, Marinova, Nurture Aqua Technology Pvt., New England Biolabs, Pices, Pml Application Ltd., Sea Run Holdings, Inc., Shell Marine Products, Sanosil Biotech, and Samudra Biopharma Private Limited.
The global blue biotechnology market has been segmented into:
Global Blue Biotechnology Market: By Product Type
Pharma
Biofuels
Food
Enzymes
Biopolymers
Others
Global Blue Biotechnology Market: By Application
Vaccine development
Drug finding
Genomics
Others
Global Blue Biotechnology Market: By End- User
Pharmaceutical companies
Biotechnology companies
Research organization
Healthcare centre
Others
Global Blue Biotechnology Market: By Geography
North America
o U.S.
o Canada
o Mexico
Europe
o U.K.
o France
o Germany
o Italy
o Rest of Europe
Asia Pacific
o India
o China
o Japan
o Rest of Asia Pacific
Middle East and Africa
o South Africa
o Rest of Middle East and Africa
Latin America
o Brazil
o Rest of Latin America
READ MORE

Scope

1 RESEARCH METHODOLOGY, ASSUMPTIONS AND ACRONYMS

2 EXECUTIVE SUMMARY

2.1 GLOBAL BLUE BIOTECHNOLOGY MARKET

3 GLOBAL BLUE BIOTECHNOLOGY MARKET-MARKET OVERVIEW

3.1 INTRODUCTION

3.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

3.1.2 GLOBAL BLUE BIOTECHNOLOGY MARKET SNAPSHOT

4 GLOBAL BLUE BIOTECHNOLOGY MARKET OVERVIEW- BY PRODUCT TYPE

4.1 INTRODUCTION

4.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY PRODUCT TYPE

4.1.1.1 PHARMA

4.1.1.2 BIOFUELS

4.1.1.3 FOOD

4.1.1.4 ENZYMES

4.1.1.5 BIOPOLYMERS

4.1.1.6 OTHERS

5 GLOBAL BLUE BIOTECHNOLOGY MARKET ANALYSIS AND FORECAST, BY APPLICATION

5.1 INTRODUCTION

5.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY APPLICATION

5.1.1.1 VACCINE DEVELOPMENT

5.1.1.2 GENOMICS

5.1.1.3 DRUG FINDING

5.1.1.4 OTHERS

6 GLOBAL BLUE BIOTECHNOLOGY MARKET ANALYSIS AND FORECAST, BY END- USER

6.1 INTRODUCTION

6.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY END- USER

6.1.1.1 PHARMACEUTICAL COMPANIES

6.1.1.2 BIOTECHNOLOGY COMPANIES

6.1.1.3 RESEARCH ORGANIZATION

6.1.1.4 HEALTHCARE SECTOR

7 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET, BY REGION

7.1 INTRODUCTION

7.2 KEY TAKEWAYS

8 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

8.1 MARKET DYNAMICS

8.1.1 DRIVERS

8.1.2 RESTRAINTS

8.1.3 OPPORTUNITIES

8.2 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE

8.3 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION

8.4 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER

8.5 U.S.

8.6 CANADA

8.7 MEXICO

9 EUROPE BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

9.1 MARKET DYNAMICS

9.1.1 DRIVERS

9.1.2 RESTRAINTS

9.1.3 OPPORTUNITIES

9.2 EUROPE BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE

9.3 EUROPE BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION

9.4 EUROPE BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER

9.5 U.K.

9.6 FRANCE

9.7 GERMANY

9.8 ITALY

9.9 SPAIN

9.10 REST OF EUROPE

10 ASIA PACIFIC BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

10.1 MARKET DYNAMICS

10.1.1 DRIVERS

10.1.2 RESTRAINTS

10.1.3 OPPORTUNITIES

10.2 ASIA PACIFIC BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE

10.3 ASIA PACIFIC BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION

10.4 ASIA PACIFIC BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER

10.5 INDIA

10.6 CHINA

10.7 JAPAN

10.8 REST OF ASIA PACIFIC

11 MIDDLE EAST AND AFRICA (MEA) BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

11.1 MARKET DYNAMICS

11.1.1 DRIVERS

11.1.2 RESTRAINTS

11.1.3 OPPORTUNITIES

11.2 MEA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE

11.3 MEA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION

11.4 MEA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER

11.5 SOUTH AFRICA

11.6 REST OF MIDDLE EAST AND AFRICA

12 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

12.1 MARKET DYNAMICS

12.1.1 DRIVERS

12.1.2 RESTRAINTS

12.1.3 OPPORTUNITIES

12.2 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE

12.3 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION

12.4 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER

12.5 BRAZIL

12.6 REST OF LATIN AMERICA

13 COMPETATIVE LANDSCAPE

13.1 GLOBAL BLUE BIOTECHNOLOGY MARKET-COMPANY MARKET SHARE ANALYSIS

14 COMPANY PROFILES: (REVENUE, PRODUCTS/BRAND OFFERINGS, COMPANY HIGHLIGHTS)

14.1 AKER BIOMARINE

14.2 CELLGEN BIOLOGICALS PVT LTD.

14.3 DONALD DANFORTH PLANT SCIENCE CENTER

14.4 GEOMARINE BIOTECHNOLOGIES

14.5 GLYCOMAR

14.6 MARINOVA

14.7 NURTURE AQUA TECHNOLOGY PVT.

14.8 NEW ENGLAND BIOLABS

14.9 PICES

14.10 PML APPLICATION LTD.

14.11 SEA RUN HOLDINGS, INC

14.12 SHELL MARINE PRODUCTS

14.13 SANOSIL BIOTECH

14.14 SAMUDRA BIOPHARMA PRIVATE LIMITED

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS